Table 2.

Geographic location and percent of Candidabloodstream infections attributable to C. albicans(SENTRY Program, 1997 to 1999)

LocationaNo. of isolates%C. albicans
United States
 New Mexico2282
 New York-12941
 New York-23837
 New York-34470
 North Carolina1735
 Nova Scotia3471
Latin America
  • a Only those sites with ≥10 BSI isolates are shown. Where results were available for more than one site within a state or country, the numerical suffix indicates the individual site.